Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure (GenePHIT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05598333 |
|
Recruitment Status :
Recruiting
First Posted : October 28, 2022
Last Update Posted : May 6, 2024
|
Sponsor:
Asklepios Biopharmaceutical, Inc.
Information provided by (Responsible Party):
Asklepios Biopharmaceutical, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2030 |
| Estimated Study Completion Date : | December 2030 |